Natural Course of Initially Metabolic Healthy Obese Individuals (Healthy Obesity)?
NCT ID: NCT06799897
Last Updated: 2025-05-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
300 participants
OBSERVATIONAL
2023-01-18
2026-01-18
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
1. What distinguishes obese persons without metabolic diseases from those with medical diseases in a cross-sectional comparison?
2. Which factors drive the conversions from metabolically healthy obesity into a metabolically unhealthy obesity in a longitudinal approach?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Metabolic Phenotyping for Personalized Obesity Therapy
NCT06874270
How Metabolism Affects Weight Loss and Gain
NCT06860776
A Prospective Cohort Study on Patient With Obesity Undergoing Weight Change
NCT07239167
Effects of Obesity Treatments on Food Preferences and Metabolism
NCT01724060
Metabolism Associated With Abdominal Fat Mass Distribution
NCT01726647
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 and 60 years
* BMI 30-50 kg/m2
* Knowledge of German, which requires sufficient written and allow oral patient education
* Blood pressure \< 140/90 mmHg
* Normal glucose metabolism
* HbA1c \< 6.5 %
* Fasting Glucose \< 7.0 mmol/l
* Normal lipid metabolism
o LDL-cholesterol \< 5.0 mmol/l
* ≤ 2 of the following metabolic syndrome criteria combined (excluding waist circumference)
* TG \> 1.7 mmol/l
* HDL-cholesterol \> 1.0 mmol/l (male) / \> 1.3 mmol/l (female)
* Fasting glucose ≥ 5.6 mmol/l
* BP ≥ 130/85 mmHg
Exclusion Criteria
* Medication and / or pathologies that prevent a safe execution of the fat tissue biopsies
* History of or planned bariatric operation
* Medical conditions that prevent examinations and testing (e.g. symptomatic cardiovascular diseases)
* Active Malignant tumor (\<2a remission)
18 Years
60 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
ETH Zurich
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jörg Goldhahn, Prof.
Role: STUDY_CHAIR
dTIP / ETH Zürich
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
dTIP / ETH Zürich
Baden, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-03031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.